Eco Animal Health Regulatory Approval
14 August 2017 - 4:00PM
UK Regulatory
TIDMEAH
ECO Animal Health Group plc(AIM: EAH)
ECO RECEIVES TURKISH MARKETING AUTHORISATION FOR AIVLOSIN® FOR
CHICKENS LAYING EGGS FOR HUMAN CONSUMPTION
ECO Animal Health Group plc is pleased to announce that its
subsidiary ECO Animal Health Limited (ECO) has received a marketing
authorisation from the General Directorate of Food and Control of
the Ministry of Food, Agriculture and Livestock of Turkey for the
use of Aivlosin® 625 mg/g water soluble granules in chickens laying
eggs for human consumption.
This approval allows ECO to start selling Aivlosin® in Turkey
for the medication of drinking water for the treatment of
infections caused by Mycoplasma in poultry laying eggs for human
consumption, with a zero day drug withdrawal period for eggs.
ECO has begun the process of submitting the EU approved
Aivlosin® regulatory files for the treatment of layers in numerous
other key egg producing markets.
Aivlosin®, ECO's patented antimicrobial, is used under
veterinary prescription for the treatment of a variety of
economically important respiratory and enteric (gut) diseases in
poultry and pigs.
Peter Lawrence, Chairman of ECO, commented "Turkey is ranked as
a global top ten egg producing country and exports eggs to both EU
member countries and to the Middle East. This latest approval is
another important step in the development of Aivlosin® for
commercial layers and demonstrates ECO's continued progress to
becoming a major force in the international market for veterinary
pharmaceutical products for livestock."
This announcement contains inside information.
Contacts:
ECO Animal Health Group plc
Peter Lawrence 020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
Peel Hunt LLP (Nominated Adviser)
Dan Webster, Adrian Trimmings, George Sellar 020 7418 8900
N+1 Singer (Joint Broker) 020 7496 3000
Mark Taylor, Brough Ransom
ECO Animal Health Group plc is a leader in the development,
registration and marketing of pharmaceutical products for animals.
Our products for these global growth markets promote well-being.
Our financial goals are achieved through the careful and
responsible application of science to generate value for our
shareholders
View source version on businesswire.com:
http://www.businesswire.com/news/home/20170813005025/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
August 14, 2017 02:00 ET (06:00 GMT)
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Apr 2024 to May 2024
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From May 2023 to May 2024
